by Zhonghan Sun, Mengkun Shi, Yan Zheng Circulating microbiome-related metabolites have emerged as promising biomarkers for coronary heart disease. A recent multi-stage study in PLOS Medicine strengthens signal prioritization but highlights the persistent gap between association and causality.
Circulating microbiome-related metabolites have emerged as promising biomarkers for coronary heart disease. In this Perspective, Yan Zheng and colleagues highlight a recent multi-stage study that strengthens signal prioritization but highlights the persistent gap between association and causality.
PLOS Medicine published a clinical update in Research Highlights on 15 Apr 2026. The item focuses on Interpreting circulating microbiome-related metabolites in coronary heart disease. Open the detail page to review the full original feed content.